Applied Pharma Research (APR)

In 2011, Norgine in-licensed SETOFILM® (Ondansetron RapidFilm® 4mg and 8mg) for chemotherapy and radiotherapy induced nausea and post-operative nausea in adults and children from Applied Pharma Research s.a. (APR). Norgine’s rights cover Europe, Australia, New Zealand, South Africa, North Africa and the Middle East.